Several biotech companies are advancing cancer research with promising clinical milestones, focusing on innovative immunotherapies and targeted treatments amid rising cancer incidence and potential research funding challenges.

EmergingGrowth.com announced the schedule for its 84th conference featuring presentations from multiple public companies across technology, biotech, and other sectors on July 16-17, 2025.

EmergingGrowth.com announces the schedule for the 78th Emerging Growth Conference, featuring presentations from various companies across different growth sectors.

GeoVax Labs, a biotechnology company, announced that its CEO will present at the NobleCon20 conference. The company is developing COVID-19 vaccines and cancer immunotherapies, with its lead clinical programs being GEO-CM04S1 and Gedeptin.

GeoVax Labs announced progress in its COVID-19 vaccine trials, including the BARDA/Project NextGen Phase 2b trial and upcoming data readouts from existing Phase 2 trials. The company also provided updates on its Gedeptin and GEO-MVA Mpox vaccine programs.